This website is not owned by Johnson & Johnson Medical Pty. Ltd, and we do not review or control the content of this website. Products discussed on this website may not be approved for use or may be approved for different indications in your country. Before using any medical device, review all relevant Instructions for Use, Package Inserts or Summary of Product Characteristics. We do not endorse the use or promotion of unapproved products or indications. Any demonstrations of approved medical devices should be considered as information only and are not a surgical training guide.
Shaping the Future of Surgery
In hospitals around the world, surgeons operate with confidence using trusted surgical systems and instruments designed to provide the safe and effective treatment for a range of medical conditions.
Jump to Content:
From manufacturing sutures, to revolutionising surgery with minimally invasive procedures, Ethicon has made significant contributions to surgery for more than 100 years. Our continuing dedication to Shape the Future of Surgery is built on our commitment to address the world’s most pressing healthcare issues and help improve and save more lives.
Ethicon offers the most complete energy portfolio for open and laparoscopic procedures. Our focus is to solve unmet surgical needs through our in-depth knowledge of tissue and energy sciences to help improve patient outcomes.
Ethicon remains a worldwide leader in the development of advanced tissue management, including surgical stapling and endocutter technologies. Ethicon provides surgeons with advanced instrumentation across the spectrum of surgical methods—all designed to support optimal patient outcomes. The wide range of options ensures the right solutions for the right procedures.
Our Ethicon portfolio of adjunctive haemostats is dedicated to aiding surgery by focusing on an array of biosurgery technologies to minimise intra- and postoperative complications. Solutions comprise innovative, biologically based products for surgical conditions that are often difficult or expensive to manage—such as problematic bleeding.
Every type of tissue, whether skin, fascia or organ, has its own specialised function and needs. Ethicon is leading advancements in wound closure that are transforming surgery. Our comprehensive wound closure portfolio lets surgeons match the specific wound healing needs of each tissue type to the appropriate closure device.
Over a Century of Meaningful Innovation
At Ethicon, we’re focused on improving health outcomes for patients and helping solve the greatest health challenges… with only meaningful innovation. The kind that led to the creation of sutures, that helped revolutionise surgery with minimally invasive procedures, and that elevates the standards of care around the world.
1887 — Sterile Sutures
Johnson & Johnson’s mass production of sterile sutures and other products ushered in the widespread practice of modern antiseptic surgery that dramatically raised survival rates.
© 2021 Johnson & Johnson Medical Pty Ltd. This site is published by Johnson & Johnson Medical Pty Ltd which is solely responsible for its contents.
This site is intended for Healthcare Professionals from Australia only.
Ethicon is a business unit of Johnson & Johnson Medical Pty Limited. 1-5 Khartoum Road, North Ryde, NSW 2113, ABN 85 000 160 403.